BacTech Environmental (BAC) AI Stock Analysis

• Market Cap: C$10.62M
• Dividend Yield: N/A
• Average Volume (3M): 70.71K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.96
• Revenue Growth: N/A
• EPS Growth: 35.14%
• Country: CA
• Employees: N/A
• Sector: Industrials
• Sector Strength: 90
• Industry: Waste Management
• EPS (TTM): N/A
• Shares Outstanding: 193,035,830
• 10 Day Avg. Volume: 87,756
• 30 Day Avg. Volume: 70,712
• PEG Ratio: -0.80
• Price to Book (P/B): -2.58
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -14.72
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 22 Underperform
• Price Target: ―

BacTech Environmental is in a challenging financial position with no revenue and negative equity, greatly impacting its overall score. While the technical analysis shows some positive short-term momentum, the poor financials and valuation significantly outweigh these factors, leading to a low overall stock score.

BacTech Environmental Business Overview & Revenue Model

Company Description

BacTech Environmental Corporation operates as an environmental technology company. It develops and commercializes BACOX, a proprietary bioleaching technology for the reclamation of mine tailings. The company's technology utilizes bacteria to extract precious and base metals, as well as to treat difficult-to-treat sulphide ores and concentrates. It holds interests in the projects in Ecuador and East Africa. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

How the Company Makes Money

BacTech Environmental generates revenue primarily through its bioleaching technology, which is used to extract metals from environmentally problematic mine tailings and concentrates. By processing materials that contain significant amounts of metals, the company is able to recover and sell these precious and base metals, such as gold and copper, creating a direct revenue stream. Additionally, BacTech may engage in partnerships or joint ventures with mining companies or governments to remediate contaminated sites, which can provide further income opportunities. The company's business model capitalizes on both the sale of recovered metals and the provision of environmental remediation services.

BacTech Environmental Financial Statement Overview

Summary

BacTech Environmental's financial health is precarious, with no revenue to cover operational costs, negative equity, and high reliance on external financing. This positions the company at a high risk of financial distress unless it can improve revenue generation and manage liabilities.

Income Statement

BacTech Environmental shows no revenue over the periods observed, resulting in negative gross, EBIT, and net profit margins. The lack of revenue and consistent losses indicate severe challenges in generating income, leaving the company with limited financial flexibility.

Balance Sheet

The company has negative stockholders' equity, indicating liabilities exceed assets, which is a serious financial concern. A high debt-to-equity ratio suggests significant leverage, and the negative equity ratio highlights a potential risk for solvency issues.

Cash Flow

Operating cash flows are negative, and the company relies heavily on financing activities to cover its cash outflows. The free cash flow remains negative, which could hinder growth and sustainability without additional funding.

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
0.00	0.00	0.00	0.00	0.00	0.00
	Gross Profit
-31.79K	-160.68K	―	―	―	―
	EBIT
-1.70M	-1.73M	-3.37M	-1.56M	-135.77K	-516.74K
	EBITDA
-641.04K	-3.00	0.00	-1.36M	0.00	20.00K
	Net Income Common Stockholders
-1.86M	-1.92M	-3.20M	-1.60M	475.75K	-1.38M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
25.90K	73.20K	10.15K	64.28K	19.41K	5.02K
	Total Assets
139.81K	1.45M	1.14M	234.97K	33.67K	34.16K
	Total Debt
908.14K	1.44M	1.03M	160.00K	825.79K	1.11M
	Net Debt
882.25K	1.37M	1.02M	95.72K	806.38K	1.11M
	Total Liabilities
3.39M	3.66M	3.09M	1.65M	2.83M	4.23M
	Stockholders Equity
-3.25M	-2.22M	-1.95M	-1.42M	-2.80M	-4.20M
Cash Flow		Free Cash Flow
-590.00K	-1.79M	-4.18M	-1.19M	-147.12K	-253.85K
	Operating Cash Flow
-591.46K	-1.79M	-3.20M	-1.19M	-147.12K	-253.85K
	Investing Cash Flow
0.00	0.00	-980.56K	0.00	0.00	0.00
	Financing Cash Flow
575.80K	1.85M	3.15M	1.24M	161.52K	232.97K

BacTech Environmental Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.06
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BAC, the sentiment is Negative. The current price of 0.06 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and above the 200-day MA of 0.04, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 47.50 is Neutral, neither overbought nor oversold. The STOCH value of 77.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:BAC.

BacTech Environmental Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	66 Neutral	$4.50B	12.29	5.40%	248.66%	4.13%	-12.33%
ECO	48 Neutral	C$234.94M	―	-3.46%	―	29.27%	42.35%
AMY	45 Neutral	C$13.15M	―	-25.82%	―	―	52.14%
LEM	40 Underperform	C$49.89M	―	-12.61%	―	―	13.91%
GEM	32 Underperform	C$1.64M	―	-57.97%	―	―	53.47%
MMS	32 Underperform	$2.00M	―	-53.12%	―	―	-2147.62%
BAC	22 Underperform	C$10.62M	―	55.19%	―	―	35.14%

BacTech Environmental Corporate Events

BacTech Environmental Secures Lucrative Royalty Deal

BacTech Environmental Corporation has secured CBOE approval for a royalty sale to Silver Crown Royalties Inc., providing a significant boost to BacTech’s financial outlook. The deal strengthens BacTech’s balance sheet with potential CAD$4 million in shares and offers upfront capital for its bioleaching facility in Ecuador, while maintaining focus on core operations. This 10-year agreement ensures long-term collaboration, aligning financial support with project milestones.